Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

New combination meningitis/hepatitis vaccine approved

Oct. 11, 1996

Fujisawa pursues new indications for tacrolimus

Oct. 11, 1996

Successful reversal of acute kidney graft rejection with Thymoglobulin

Oct. 11, 1996

BioTransplant's transplant technologies covered by four new patents

Oct. 11, 1996

Evidence indicates wider application of VasoCare therapy

Oct. 11, 1996

Cytel-Baxter xenotransplantation collaboration

Oct. 11, 1996

First recombinant DTaP vaccine submitted for FDA approval

Oct. 11, 1996

SangStat's ciclosporin bioequivalent to Sandoz drug

Oct. 11, 1996

Cel-Sci forms collaboration for development of herpesvirus vaccine

Oct. 11, 1996

Protein Design Labs' humanized antibody effective in reducing kidney transplant rejection

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...